Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
暂无分享,去创建一个
[1] Wei Han,et al. A case of 2019 novel coronavirus infected pneumonia with twice negative 2019-nCoV nucleic acid testing within 8 days. , 2020, Chinese medical journal.
[2] L. Yang,et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.
[3] Oon Tek Ng,et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. , 2020, JAMA.
[4] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[5] MingKun Li,et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Huanqin Han,et al. SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients , 2020, The Lancet Infectious Diseases.
[7] Don Klinkenberg,et al. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[9] Dylan H. Morris,et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 , 2020, The New England journal of medicine.
[10] Ivan Griffin,et al. COVID-19: combining antiviral and anti-inflammatory treatments , 2020, The Lancet Infectious Diseases.
[11] Jizhen Ren,et al. Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis , 2020, Journal of medical virology.
[12] Jianjun Gao,et al. Discovering drugs to treat coronavirus disease 2019 (COVID-19). , 2020, Drug discoveries & therapeutics.
[13] G. Lippi,et al. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19) , 2020, European journal of preventive cardiology.
[14] Yan Zhao,et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) , 2020, Military Medical Research.
[15] Wei Han,et al. A case of coronavirus disease 2019 with twice negative nucleic acid testing within 8 days , 2020, Chinese Medical Journal.
[16] Liang Peng,et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report , 2020, International Journal of Infectious Diseases.
[17] Taiwen Li,et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa , 2020, International Journal of Oral Science.
[18] S. Cauchemez,et al. Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature , 2014, BMC Infectious Diseases.
[19] G. Chowell,et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[20] G. Lippi,et al. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks , 2020, Clinical chemistry and laboratory medicine.
[21] R. Lu,et al. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.
[22] Cecile Viboud,et al. Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project , 2019, Journal of global health.
[23] Elisabeth Mahase. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction , 2020, BMJ.
[24] Pengfei Sun,et al. Clinical characteristics of hospitalized patients with SARS‐CoV‐2 infection: A single arm meta‐analysis , 2020, Journal of medical virology.
[25] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[26] G. Lippi,et al. Which lessons shall we learn from the 2019 novel coronavirus outbreak? , 2020, Annals of translational medicine.
[27] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[28] G. Lippi,et al. The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge , 2020, Diagnosis.
[29] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[30] Mario Plebani,et al. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis , 2020, Clinica Chimica Acta.
[31] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[32] Jing Zhao,et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.
[33] N. Linton,et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19) , 2020, International Journal of Infectious Diseases.
[34] MingKun Li,et al. Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] Mario Plebani,et al. Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.
[36] G. Remuzzi,et al. COVID-19 and Italy: what next? , 2020, The Lancet.